← 홈

ADC · 고형암 (전체)

357개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 357개
ADCSBiologicDaiichi Sankyoderuxtecan (Dato-DXd, Datro…Phase 3

DS-8201a (Trastuzumab deruxtecan, Trastuzumab deruxtecan (DS-8201a))

Breast Cancer; Non-small Cell Lung Carcinoma · Breast Cancer

#BreastCancer#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 79.7%임상시험 84상태 RECRUITING
ADCABiologicDaiichi Sankyoderuxtecan (Dato-DXd, Datro…Phase 2

T-DXd, DS-8201a (Trastuzumab deruxtecan, Trastuzumab deruxtecan (T-DXd, DS-8201a))

Advanced Breast Cancer; Advanced Breast Carcinoma · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 79.7%임상시험 84상태 RECRUITING
ADCCBiologicShanghai Hansoh Biomedical Co.,…GQ1001Phase 1

Phase Ia: Dose escalation (HS-20093, HS-20093 (Phase Ia: Dose escalation))

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#인기#항체약물접합체+4
임상시험 79상태 ACTIVE
ADCCBiologicNovartis PharmaceuticalsdeliveryPhase 3

Trametinib (Trametinib)

KRAS G12C Mutant Solid Tumors; Carcinoma, Non-Small Cell Lung · FRα

#FR#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 100%임상시험 79상태 DISCONTINUED
ADCCBiologicEli Lilly and CompanyPhase 2

Abemaciclib (Abemaciclib)

Advanced Cancer; Metastatic Melanoma · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 32.9%임상시험 77상태 RECRUITING
ADCCBiologicHoffmann-La RochePhase 2

Cobimetinib (Cobimetinib)

Metastatic Thyroid Gland Carcinoma; Poorly Differentiated Thyroid Gland Carcinoma · Advanced Breast Carcinoma

#AdvancedBreastCarcinoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 67.6%임상시험 77상태 DISCONTINUED
ADCBBiologicAmgensPhase 3

Sunitinib (Sunitinib)

Advanced Solid Tumors · Lymphoma, Non-Hodgkin

#LymphomaNon-Hodgkin#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 78%임상시험 76상태 RECRUITING
ADCBBiologicSuzhou Transcenta Therapeutics …Govitecan in Untreated, Adv…Phase 2

Albumin-bound paclitaxel (Albumin-bound paclitaxel)

Advanced Cancer; Gastric Cancer · Solid Cancer

#SolidCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 63.5%임상시험 75상태 RECRUITING
ADCCBiologicOHSU Knight Cancer InstitutePhase 2

Niraparib (Niraparib)

Advanced Breast Carcinoma; Advanced Malignant Solid Neoplasm · Advanced Breast Carcinoma

#AdvancedBreastCarcinoma#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 88%임상시험 75상태 DISCONTINUED
ADCCBiologicBristol-Myers SquibbDM4, indicating activation …Phase 2

Vemurafenib (Vemurafenib)

Metastatic Thyroid Gland Carcinoma; Poorly Differentiated Thyroid Gland Carcinoma · Advanced Breast Carcinoma

#AdvancedBreastCarcinoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 94%임상시험 74상태 DISCONTINUED
ADCBiologicHansoh BioMedical R&D Companyvedotin with pembrolizumabPhase 3

Cisplatin / carboplatin (Cisplatin / carboplatin)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 84%임상시험 67상태 RECRUITING
ADCBiologicAstellasvedotin (ARON-2EV study)Phase 2

EV (Enfortumab vedotin-ejfv, Enfortumab vedotin-ejfv (EV))

Urothelial Cancer; Metastatic Urothelial Carcinoma · Urothelial Cancer

#UrothelialCancer#ADC#Phase2#인기#항체약물접합체+5
임상시험 67상태 RECRUITING
ADCBiologicAstraZenecaVedotin in a Hemodialysis P…Phase 3

Gemcitabine/Carboplatin (Gemcitabine/Carboplatin)

Non-Small-Cell Lung Carcinoma NSCLC · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 69.6%임상시험 67상태 ACTIVE
ADCBiologicAstraZenecaPhase 3

Pemetrexed/Carboplatin (Pemetrexed/Carboplatin)

Non-Small-Cell Lung Carcinoma NSCLC · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 87.5%임상시험 67상태 RECRUITING
ADCBiologicRemeGenvedotin plus PD-1 blockade …Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin(RC48) Plus Tratuzumab)

HER2-positive Gastric Cancer; HER2-positive Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
임상시험 66상태 RECRUITING
ADCBiologicMerck Sharp & Dohme LLCvedotin combined with pembr…Phase 2

Immune Checkpoint Inhibitor (Immune Checkpoint Inhibitor)

Unspecified Adult Solid Tumor, Protocol Specific · Gastric Cancer

#GastricCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 59%임상시험 66상태 RECRUITING
ADCBiologicNovartis PharmaceuticalsPhase 2

Ribociclib (Ribociclib)

KRAS G12C Mutant Solid Tumors; Carcinoma, Non-Small Cell Lung · Breast Cancer

#BreastCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 66.7%임상시험 66상태 RECRUITING
ADCBiologicDaiichi SankyoDM1) and trastuzumab deruxt…Phase 3

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201)

Breast Cancer; HER2-positive Breast Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 65.8%임상시험 66상태 RECRUITING
ADCBiologicAlterome Therapeutics, Inc.sPhase 1

midazolam (midazolam)

Cancer; PDAC - Pancreatic Ductal Adenocarcinoma · Carcinomas

#Carcinomas#ADC#Phase1#인기#항체약물접합체+5
임상시험 66상태 ACTIVE
ADCBiologicMerck Sharp & Dohme LLCPhase 2

Corticosteroid (Corticosteroid)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 5.6%임상시험 65상태 RECRUITING

2 / 18 페이지

← 이전다음 →